1. Home
  2. SLAI vs BGLC Comparison

SLAI vs BGLC Comparison

Compare SLAI & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SLAI

SOLAI Limited American Depositary Shares (each representing one hundred (100) Class A Ordinary Shares)

N/A

Current Price

$1.06

Market Cap

12.5M

Sector

Technology

ML Signal

N/A

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

N/A

Current Price

$3.63

Market Cap

10.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SLAI
BGLC
Founded
2001
2017
Country
United States
Malaysia
Employees
N/A
N/A
Industry
EDP Services
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.5M
10.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SLAI
BGLC
Price
$1.06
$3.63
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
929.5K
10.5K
Earning Date
02-27-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$24,209,000.00
$9,465,006.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.21
52 Week Low
$0.63
$2.01
52 Week High
$8.07
$15.60

Technical Indicators

Market Signals
Indicator
SLAI
BGLC
Relative Strength Index (RSI) N/A 31.92
Support Level N/A $3.69
Resistance Level N/A $3.89
Average True Range (ATR) 0.00 0.14
MACD 0.00 -0.01
Stochastic Oscillator 0.00 9.43

Price Performance

Historical Comparison
SLAI
BGLC

About SLAI SOLAI Limited American Depositary Shares (each representing one hundred (100) Class A Ordinary Shares)

SOLAI Ltd is a technology-driven cryptocurrency infrastructure company. It is expanding from its foundation in crypto mining to build a blockchain-based ecosystem spanning AI, stablecoins, and payment infrastructure, and Solana treasury and staking operations supporting use cases across institutional settlement, commerce, consumer payments, and AI-native agent transactions. The group is leveraging its blockchain and data infrastructure expertise, aiming to enhance on-chain efficiency and expand participation across Solana and other blockchain ecosystems.

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

Share on Social Networks: